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Translation repression by RNA interference (RNAi) has 
emerged in recent years as a ubiquitous, powerful, and 
precise method for the regulation of gene expression, 
both naturally and experimentally. In this process, a 
messenger RNA (mRNA), made from a gene and destined 
to be translated into a protein, is silenced by a molecule of 
“interfering” RNA.
At least two related processes fall under the heading of 
RNAi; in each, the interfering RNA is a small molecule 
(about 21 nucleotides long) that binds to a matching 
sequence on the mRNA. Exactly what happens next 
depends on how close the match is. Perfect complementarity 
(involving so-called small interfering RNAs, or siRNAs) 
results in mRNA degradation, while an imperfect match leads 
to silencing of the message without degradation.
In this latter, non-degrading, form of interference, which 
has been widely observed in organisms from plants to people, 
the imperfectly complementary RNA is called a microRNA 
(miRNA), and is part of a large complex called the RISC 
(RNA-induced silencing complex). Neither the full structure 
of the RISC nor the details of its function are known, but 
several components have been identiﬁ  ed, including the 
cleaving enzyme Dicer and the argonaute proteins Ago1 and 
Ago2. In the cytoplasm, after RISC binds to target mRNA, 
it accumulates in so-called P-bodies—poorly characterized 
multi-protein complexes that contain, among other things, 
the protein RCK/p54. In a new study, Chia-ying Chu and 
Tariq Rana demonstrate that, through its direct interactions 
with the argonaute proteins, and its promotion of P-body 
formation, RCK/p54 plays a key role in miRNA-mediated, but 
not siRNA-mediated, translation repression.
The authors began by determining which P-body proteins 
can bind to which RISC proteins, using ﬂ  uorescent tags to 
mark the various proteins. They found that Ago2 formed 
complexes with most of the known players. But they reasoned 
that the RNA scaffolding of the P-body likely causes many 
proteins to associate without actually binding to one another, 
and so, to rule out nonspeciﬁ  c effects, they digested the RNA 
out of the preparation. This left only RCK/p54 and Ago1 
clinging to Ago2, indicating a true direct interaction. They 
next asked whether RCK/p54, ﬁ  rst identiﬁ  ed in P-bodies, 
was also a component of the active RISC. By purifying active 
complexes and analyzing their composition, they showed 
that it was—when a RISC was activated by the presence of a 
microRNA, it also contained RCK/p54.
When the authors suppressed expression of RCK/p54 
(neatly enough, by using an siRNA against it), P-bodies were 
disrupted, and Ago2 dispersed throughout the cytoplasm, 
suggesting RCK/p54 is responsible for the localization 
of Ago2 in P-bodies. P-bodies could also be disrupted by 
suppressing another protein, Lsm1; when this occurred, 
though, RCK/p54 still associated with Ago2 and with the 
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RISC, indicating that these interactions do not depend on the 
presence of P-bodies.
RCK/p54 depletion also provided the authors with another 
important insight: loss of RCK/p54 did not prevent siRNA-
mediated RNA cleavage—the form of translation repression 
that depends on exact complementarity between an siRNA 
and mRNA. It did, however, lead to an increase in translation 
of known microRNA targets, consistent with a role for 
RCK/p54 in the second, non-degrading, form of translation 
repression, mediated by miRNA.
Taken together, these results suggest that RCK/p54 forms 
part of the RISC in association with the argonaute proteins; 
that its previously identiﬁ  ed association with P-bodies is a 
consequence of its function in the RISC; and that it plays a 
key role in miRNA-mediated translation repression. These 
results not only shed light on this important and poorly 
understood system for controlling gene expression, but also, 
because RCK/p54 appears to play no role in siRNA-mediated 
repression, they lay the groundwork for developing a detailed 
understanding of the similarities and differences between 
these two important pathways to RNAi.
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